you are here:

Ipca Laboratories Ltd.

BSE: 524494 | NSE: IPCALAB |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE571A01020 | SECTOR: Pharmaceuticals

BSE Live

Dec 06, 16:00
2020.00 -19.75 (-0.97%)
Volume
AVERAGE VOLUME
5-Day
19,057
10-Day
20,746
30-Day
14,141
19,901
  • Prev. Close

    2039.75

  • Open Price

    2030.00

  • Bid Price (Qty.)

    2015.20 (25)

  • Offer Price (Qty.)

    2020.00 (17)

NSE Live

Dec 06, 16:09
2015.80 -23.25 (-1.14%)
Volume
AVERAGE VOLUME
5-Day
2,533,650
10-Day
1,764,269
30-Day
805,383
865,164
  • Prev. Close

    2039.05

  • Open Price

    2039.00

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    2015.80 (1135)

Financials

2020 2019 2018 2017 2016
Quarterly Results of Ipca Laboratories (in Rs. Cr.) Sep '21 Jun '21 Mar '21 Dec '20 Sep '20  
Net Sales/Income from operations 1,423.84 1,478.60 1,040.92 1,315.22 1,297.77  
Other Operating Income -- -- -- -- --  
Total Income From Operations 1,423.84 1,478.60 1,040.92 1,315.22 1,297.77  
EXPENDITURE  
Consumption of Raw Materials 404.42 404.08 409.30 377.72 405.78  
Purchase of Traded Goods 57.65 52.14 69.93 61.60 32.78  
Increase/Decrease in Stocks 14.08 41.97 -178.15 28.08 -32.00  
Power & Fuel -- -- -- -- --  
Employees Cost 276.64 280.64 237.80 230.03 239.09  
depreciat 50.50 49.96 48.57 47.66 46.26  
Excise Duty -- -- -- -- --  
Admin. And Selling Expenses -- -- -- -- --  
R & D Expenses -- -- -- -- --  
Provisions And Contingencies -- -- -- -- --  
Exp. Capitalised -- -- -- -- --  
Other Expenses 312.03 305.79 285.40 268.96 291.96  
P/L Before Other Inc. , Int., Excpt. Items & Tax 308.52 344.02 168.07 301.17 313.90  
Other Income 15.07 13.61 19.91 15.65 15.00  
P/L Before Int., Excpt. Items & Tax 323.59 357.63 187.98 316.82 328.90  
Interest 1.47 1.26 2.31 1.56 1.81  
P/L Before Exceptional Items & Tax 322.12 356.37 185.67 315.26 327.09  
Exceptional Items -- -- -- -- --  
P/L Before Tax 322.12 356.37 185.67 315.26 327.09  
Tax 64.48 71.65 34.19 55.29 51.41  
P/L After Tax from Ordinary Activities 257.64 284.72 151.48 259.97 275.68  
Prior Year Adjustments -- -- -- -- --  
Extra Ordinary Items -- -- -- -- --  
Net Profit/(Loss) For the Period 257.64 284.72 151.48 259.97 275.68  
Equity Share Capital 25.37 25.37 25.37 25.37 25.27  
Reserves Excluding Revaluation Reserves -- -- -- -- --  
Equity Dividend Rate (%) -- -- -- -- --  
EPS Before Extra Ordinary  
Basic EPS 20.31 22.45 11.94 20.49 21.79  
Diluted EPS 20.31 22.45 11.94 20.49 21.79  
EPS After Extra Ordinary  
Basic EPS. 20.31 22.45 11.94 20.49 21.79  
Diluted EPS. 20.31 22.45 11.94 20.49 21.79  
Public Share Holding  
No Of Shares (Crores) -- -- -- -- --  
Share Holding (%) -- -- -- -- --  
Promoters and Promoter Group Shareholding  
a) Pledged/Encumbered  
- Number of shares (Crores) -- -- -- -- --  
- Per. of shares (as a % of the total sh. of prom. and promoter group) -- -- -- -- --  
- Per. of shares (as a % of the total Share Cap. of the company) -- -- -- -- --  
b) Non-encumbered  
- Number of shares (Crores). -- -- -- -- --  
- Per. of shares (as a % of the total sh. of prom. and promoter group). -- -- -- -- --  
- Per. of shares (as a % of the total Share Cap. of the company). -- -- -- -- --  
Source : Dion Global Solutions Limited